Dimensional Fund Advisors
PASG icon

Dimensional Fund Advisors’s Passage Bio PASG Stock Holding History

Dimensional Fund Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-906
Closed -$17.3K – 3506
2023
Q1 		$17.3K Hold
906
– – ﹤0.01% 3442
2022
Q4 		$25 Sell
906
-64
-7% -$1.61K ﹤0.01% 3446
2022
Q3 		$24K Buy
970
+64
+7% +$2.52K ﹤0.01% 3457
2022
Q2 		$43K Sell
906
-32
-3% -$1.5K ﹤0.01% 3404
2022
Q1 		$58K Sell
938
-220
-19% -$18.1K ﹤0.01% 3446
2021
Q4 		$147K Buy
1,158
+428
+59% +$69.9K ﹤0.01% 3390
2021
Q3 		$145K Buy
+730
New +$174K ﹤0.01% 3389

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors's PASG Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Passage Bio (PASG) in Q2 2023, closing a stake of 906 shares — an estimated $17.3K sold.

Dimensional Fund Advisors first reported a position in PASG in Q3 2021 and held it in 7 quarters. The position peaked at $147K in Q4 2021. 54 funds tracked by Wall St. Rank hold PASG as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Passage Bio position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 906 Passage Bio shares in Q2 2023, an estimated $17.3K.
  • Dimensional Fund Advisors first reported a position in Passage Bio in Q3 2021 and held it in 7 quarters.
  • Dimensional Fund Advisors's Passage Bio position peaked at $147K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Passage Bio as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.